Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
about
Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials.Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies.Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended eventRibavirin in the treatment of SARS: A new trick for an old drug?Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection.An index to predict ribavirin-induced anemia in asian patients with chronic genotype 1 hepatitis CInterferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis CEpoetin alfa for the treatment of combination therapy-induced hemolytic anemia in patients infected with hepatitis C virus.The utility of therapeutic drug monitoring for ribavirin in patients with chronic hepatitis C--a critical review.Systematic review: Asian patients with chronic hepatitis C infection.Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin.Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals.Liquid chromatography assay for routine monitoring of cellular ribavirin levels in blood.Ribavirin for SARS in children.A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome.Treatment Related Hematologic Changes in a Population of Iranian Patients with Chronic Hepatitis C Infection from 2009 to 2014.Gender influence on treatment of chronic hepatitis C genotype 1.Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response.Cost-effectiveness of growth factors during hepatitis C anti-viral therapy.Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
P2860
Q33234511-3AD1415B-E2BB-4A39-98A3-704DB02A0628Q33430951-E0E2FBA8-DEE8-417C-97F3-24B97FF6BE34Q34254787-22F9B776-B50A-45FB-B189-14CB9A65BA4EQ34979709-87D2F047-1F85-4A10-9394-66C97039CE9DQ35205389-A0ECDCCA-3B17-4137-8AE9-7A8E2908CE17Q35226233-E42D576E-26D3-4CED-B968-132A06092B32Q35435376-73CCFBA8-6D9D-45E8-B15D-D0CEE6C334B3Q36146443-309B9771-2F82-460D-B952-8AA8A2194913Q37634196-BB0A1F97-1EDE-4D92-9CB6-EB1B8C37BFC0Q38096012-4A71C049-7AB1-4DEA-AC6B-060378F9EA81Q38707179-CD5B0D50-79C5-4E91-B980-9BF41D2E35DBQ40053677-BC057774-4C4F-42EA-B7B5-07E9BF3CC901Q40164303-88EF6044-D3F0-4A9D-A437-694B09940118Q44088975-6F3F71C8-08B8-4172-B6EB-C607CDCC7916Q44752832-C9DB744E-81F8-472F-B89A-3D7457C05F06Q47199643-CF7D86DE-8571-4706-9F1E-1B37F343701EQ50559457-892B97A1-7950-4C45-B55D-A383363CF345Q50572228-C94344B0-A23A-4BCE-9E52-CD7143D18354Q50575153-A2F19A8F-ABCD-4E80-AD1F-75D152F4CD59Q50575347-7F2D0A92-9CE6-435B-AEB1-C580F91C5838Q50582364-B45B5DF8-F039-4FDD-952C-AB60AEA67248
P2860
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
@ast
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
@en
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
@nl
type
label
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
@ast
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
@en
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
@nl
prefLabel
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
@ast
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
@en
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C.
@nl
P2860
P1476
Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2002.01326.X
P407
P577
2002-09-01T00:00:00Z